Endosense Secures $40.3 Million In Series C Financing For Medical Device Development

Endosense Secures $40.3 Million In Series C Financing For Medical Device Development, European Direct Sales of And The U.S. Launch Of TactiCath Upon Future FDA Approval As a leader in force-sensing technology focused on improving the efficacy and safety of catheter ablation…